Integrated Research Applications MOTS-C is used across multiple domains of metabolic, cardiovascular, musculoskeletal, and aging research
Combining These Peptides: Rationale and Mechanism of Action Clinical Evidence and Trial Data Available to UK Patients Safety Considerations, Side Effects, and MHRA Guidance Current Availability and Regulatory Status in the UK Speaking to a UK Healthcare Professional About These Treatments Scientific References Frequently Asked Questions What Are Cagrilintide and Retatrutide and How Do They Work
Cancer Cell 22(1):91105 Chen X et al (2016) CCL2/CCR209 regulates the tumor microenvironment in HER-2/neu-driven mammary carcinomas in mice
Kresch E, Efimenko I, Gonzalez D, Rizk PJ, Ramasamy R
On CRPUB, you can publish your new procedures or applications, explain the improvements you have made or ask any questions you may have